KA101 outperforms other clinical adjuvants in inducing balanced Th1/Th2 immunity and robust B cell responses to varicella-zoster virus glycoprotein E - Quiz - MDSpire

KA101 outperforms other clinical adjuvants in inducing balanced Th1/Th2 immunity and robust B cell responses to varicella-zoster virus glycoprotein E

  • By

  • Yaru Quan

  • Su Zhang

  • Wenwen Wang

  • Yiping Wang

  • Kangwei Xu

  • Kaiqin Wang

  • Wenyan Wan

  • Jiaojiao Nie

  • July 16, 2026

Share

Original Source(s)

KA101 outperforms other clinical adjuvants in inducing balanced Th1/Th2 immunity and robust B cell responses to varicella-zoster virus glycoprotein E

  • by Yaru Quan, Su Zhang, Wenwen Wang, Yiping Wang, Kangwei Xu, Kaiqin Wang, Wenyan Wan, Jiaojiao Nie

  • July 16, 2026

Related Content

Case Report: Persistent indirect hyperbilirubinemia caused by Gilbert syndrome misdiagnosed as drug-induced liver injury during tuberculosis treatment

The dual role of parasites and parasite-derived products in cancer biology: a systematic review of in vitro and in vivo evidence

Multidisciplinary management and outcomes of abdominal vascular graft and endograft infections: a retrospective cohort study